z-logo
open-access-imgOpen Access
Dabrafenib monotherapy in BRAF+ non-small cell lung cancer – our experience
Author(s) -
Ondřej Fischer,
Vı́tězslav Kolek,
Denisa Rozsívalová,
Tomáš Tichý,
Jozef Škarda,
Jir̆ı́ Drábek
Publication year - 2020
Publication title -
klinicka onkologie
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.204
H-Index - 13
eISSN - 1802-5307
pISSN - 0862-495X
DOI - 10.48095/ccko2020458
Subject(s) - dabrafenib , lung cancer , medicine , oncology , cancer research , cancer , vemurafenib , metastatic melanoma

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom